Division of Pediatric Cardiology, Children's National Health System, Washington, District of Columbia.
Children's National Rare Disease Institute, Children's National Health System, Washington, District of Columbia.
Am J Med Genet C Semin Med Genet. 2020 Mar;184(1):149-153. doi: 10.1002/ajmg.c.31777. Epub 2020 Feb 13.
Congenital heart disease (CHD) remains the most common birth defect, with an estimated incidence of approximately 1% of all births. The population of adults with CHD is growing rapidly with advances in medical care. Overall survival to adulthood in the current era estimated to exceed 90%. Genetic causes of CHD can be classified into several broad categories: (a) chromosomal aneuploidy, (b) large chromosomal deletion or duplication, (c) single gene mutation, and (d) copy number variation. However, only 20-30% of CHD cases have an established etiology characterized by either genetic abnormalities or environmental factors. The role of genetics in the field of adult CHD is only increasing. More adult patients with CHD are seeking genetic counseling to understand the etiology of their underlying CHD and the risks to future offspring. A multidisciplinary approach is essential to provide appropriate counseling to patients regarding indications for genetic testing and interpretations of results. Novel advances with precision medicine may soon enable clinicians to individualize therapies for a comprehensive approach to the care of adult patients with CHD.
先天性心脏病(CHD)仍然是最常见的出生缺陷,估计所有出生缺陷的发病率约为 1%。随着医疗保健的进步,患有 CHD 的成年人的人口数量正在迅速增长。在当前时代,估计总体成年生存率超过 90%。CHD 的遗传原因可分为几大类:(a)染色体非整倍体,(b)大染色体缺失或重复,(c)单基因突变,和(d)拷贝数变异。然而,只有 20-30%的 CHD 病例具有明确的病因学特征,要么是遗传异常,要么是环境因素。遗传学在成人 CHD 领域的作用只会越来越大。越来越多的 CHD 成年患者正在寻求遗传咨询,以了解其潜在 CHD 的病因以及对未来后代的风险。多学科方法对于为患者提供关于基因检测适应症和结果解释的适当咨询至关重要。精准医学的新进展可能很快使临床医生能够为 CHD 成年患者的综合治疗方法定制治疗方法。